Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Hematology General summary: This is a Researcher 1 position in the laboratories of Brad Blaser, MD, PhD (75%) and Amanda Toland, PhD (25%) at The Ohio State University. The position involves 25% lab
-
rank. This position consists of an initial 3-year appointment that is renewable based upon annual reviews. We are seeking faculty who will teach within the OT Doctoral program in the School of Health and
-
scheduled for 2026. The Ohio State University College of Medicine graduates approximately 200 medical students per year. The obstetrics and gynecology residency program is integrated with the Mount Carmel
-
. Performs soil analyses and evaluates soil quality index. Evaluates, collates, tabulates, and synthesizes data, including computer modeling and soil carbon mapping, relevant to training of farmers and for
-
for submission to peer-reviewed journals; and mentoring undergraduate and graduate students. Other responsibilities include field research program and conference presentations. Qualifications: PhD in glaciology
-
. Minimum Education Required Master’s Level Degree with a Major in bioinformatics, biostatistics, computer science, data science, or a related field. Additional Education Desired PhD Level Degree with a Major
-
University studying microbial ecology of glacier and permafrost environments. The Post Doctoral Scholar will embark on a program of independent research with the primary goal of determining how microorganisms
-
activities, including the submission of new grant applications, related to their work. Required Education: PhD in Engineering Biomechanics, Engineering Mechanics or related field Required Experience: Computer
-
Residency Program was ranked in the top 15th percentile nationwide on the Doximity Residency Navigator list. At OSUWMC Neurology faculty participate in a vibrant culture that is actively shaping the future
-
Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract